Enzo Tells Justices Fed. Circ. Set 'Lax' New Enablement Test
Enzo Life Sciences Inc. has asked the U.S. Supreme Court to overturn a decision that DNA testing patents it asserted against Abbott Laboratories and others are invalid for lack of enablement,...To view the full article, register now.
Already a subscriber? Click here to view full article